글로벌 낭포충증 치료 시장 – 2029년까지의 산업 동향 및 예측

낭포충증 치료 시장 분석 및 규모

글로벌 낭포충증 치료 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 감염의 최대 빈도는 주로 돼지고기에서 발견되는 Taenia solium 촌충 종류에 의해 발생합니다. 낭포충증 치료 채택 증가와 중국, 인도 등과 같은 발전하는 경제는 글로벌 낭포충증 치료 시장에 새로운 기회를 창출할 것입니다. COVID-19도 시장 성장에 큰 영향을 미쳤습니다.

Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 낭포충증 치료 시장의 성장률을 분석합니다. 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

시장 정의

낭포충증은 돼지 촌충 감염으로도 알려져 있으며, 주로 촌충 태니아 솔륨의 유충 낭포로 인해 발생하는 원생동물 감염으로 정의되며, 뇌, 근육 및 기타 조직에 영향을 미칩니다. 주로 오염된 음식, 체액, 피부 아래의 갑작스러운 두통 및 덩어리와 같은 더러운 손으로의 밀접한 접촉을 통해 퍼집니다. 이는 의료 분야에 매우 중요하므로 예측 기간 동안 크게 증가할 것으로 예상됩니다.

낭포충증 치료 시장 범위 및 세분화

Global Cysticercosis Treatment Market Dynamics

Drivers

• Rising Incidence of Parasitic Infection

According to the International Journal of Surgery records, Neurocysticercosis (NCC) is the most common parasitic infestation of the brain, and it is projected that almost 50 million people worldwide suffer from this disease. About, 50,000 individuals with Neurocysticercosis die each year because of the disease. Thus, this boosts the market growth.

Opportunities

• Rise in adoption of cysticercosis treatment

Increase in adoption of cysticercosis treatment in developing economies such as China and India is anticipated to offer substantial opportunities for the global cysticercosis treatment market.

• Increase in Protozoan Infections

Increase in the cases of protozoan infections globally and a lack of sanitation practices in some of the developing countries are projected to boost the cysticercosis treatment market during the forecast period. Thus, it creates an opportunity for the market growth.

Restraints/Challenges

• Complications of cysticercosis

The disease's major complications mainly include brain edema, chronic meningitis, vasculitis, paralysis, hydrocephalus, coma, partial blindness, seizures, and death. This acts as a major hindrance in the market growth.

•        Higher cost of research & development

Higher cost of research & development and increasing frequency of severe reactions, due to the body’s inflammatory reaction to the dying parasites, are major factors limiting the global cysticercosis treatment market.

This global cysticercosis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global cysticercosis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cysticercosis Treatment Market Scope

The global cysticercosis treatment market is segmented on the basis of drug, drug class, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

• Antiparasitic therapy
• Albendazole
• Corticosteroids
• Dexamethasone
• Prednisone
• Antiepileptic drugs
• Praziquantel
• Albendazole
• Surgery

Drug Type

• Branded
• Generic

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Cysticercosis Treatment Market Regional Analysis/Insights

The global cysticercosis treatment market is analysed and market size insights and trends are provided by drug, drug class, distribution channel and end-user as referenced above.

The major countries covered in the global cysticercosis treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to the high diagnostic rate and presence of sophisticated medical facilities to maximize the treatment effectiveness for patient and increase focuses in the research and development activity.

Asia-Pacific dominates the market due to the growing cases of protozoan infections, developing healthcare facilities and presence of generic companies.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Cysticercosis Treatment Market Share Analysis

The global cysticercosis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global cysticercosis treatment market.

글로벌 낭포충증 치료 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 파이저 주식회사(미국)
• F. 호프만-라 로슈 유한회사(스위스)
• 마일런 NV(미국)
• Fresenius Kabi AG(독일)
• 노바티스 AG(스위스)
• Teva Pharmaceutical Industries Ltd. (이스라엘)
• 브리스톨 마이어스 스퀴브 회사(미국)
• GSK 주식회사(영국)
• Bayer AG(독일)
• Strides Pharma Science Limited(인도)

SKU-54106